Safety and efficacy of AAIR pacing in selected patients with sick sinus syndrome

His bundle pacing - a curative method: A Case Report

INTRODUCTION

Pacing of the His bundle and conduction system seems an attractive site for pacing. Lead placement in His-pacing might be technically challenging due to surrounding structures and particular anatomic location.

PATIENT CONCERNS

A 62-years old male patient was admitted for recurrent syncope. Electrocardiographic monitoring revealed periods of complete atrioventricular block with left branch block morphology and a QRS duration of 160 ms.

DIAGNOSIS

A diagnosis of intermittent complete atrioventricular block was made with a Class I indication of permanent dual-chamber cardiac pacing.

INTERVENTIONS

A lead delivery system with a C315 His catheter and a Select Secure 3830 69 cm pacing lead was placed at the septal area of the atrioventricular junction with good pacing and sensing thresholds. An important narowing of the QRS was observed.

OUTCOMES

After the procedure, good pacing and sensing parameters were observed.Echocardiography revealed disappearance of the previously recorded ventricular dyssynchronism.Device follow-up at 1 month and 3 months showed stable pacing and sensing parameters.

CONCLUSION

Pacing the distal His bundle normalized the QRS complex, therefore "curing" both the atrioventricular and the left bundle branch conduction abnormalities. As such, the technique can be used as an alternative to cardiac electrical resynchronization therapy with acceptable pacing and detection thresholds and better ventricular activation pattern.

Left bundle branch area pacing - restoring the natural order: A Case Report

INTRODUCTION

Recent studies have shown that His-bundle pacing could be an alternative in patients requiring cardiac resynchronization therapy as it is comparable or better in terms of amelioration of ventricular activation, narrowing of the QRS complex, or clinical outcomes. However, in case of high threshold at the level of His-bundle or inability to correct conduction through a diseased His-Purkinje system other option should be searched like left bundle pacing.

PATIENT CONCERNS

A 77-year-old man presented to the Emergency Department for dizziness and dizziness and lightheadedness due to an intermittent 2:1 atrioventricular block with a QRS complex morphology of a major left branch block.

DIAGNOSIS

Given the documented symptomatic 2:1 AV block, according to the European Guideliness the patient was considered to have a class 1 indication of permanent double chamber cardiostimulation.

INTERVENTIONS

A lead delivery system with a C315 His catheter and a Select Secure 3830 69 cm pacing lead were placed at the His bundle area with important narrowing of the QRS complex but with an unacceptable high threshold. The delivery system was moved towards the apex 1,5 cm and the lead screwed deep into the septum until capture of the left bundle branch was achieved with complete normalization of the conduction troubles.

OUTCOMES

At 3 month follow-up the patient was asymptomatic and the pacing and sensing thresholds remained at same values as during implantation: 0.75/0.4 ms and 14 mV respectively.

CONCLUSION

Left bundle-pacing represents the next step of His-Purkinje system pacing to overcome all difficulties related to His-bundle pacing.

Uso Racional dos Cabos-Eletrodos na Estimulação Cardíaca Artificial

Introdução: Os dispositivos cardíacos eletrônicos implantáveis (DCEIs) são terapia consagrada para o tratamento de bradiarritmias, prevenção de morte súbita ou insuficiência cardíaca. Desde o primeiro implante de marcapasso transvenoso há mais de 60 anos, ocorreram avanços tecnológicos dos dispositivos e melhorias nas técnicas cirúrgicas. No entanto esse tipo de terapia ainda está associado a complicações significativas, a maioria relacionada ao implante dos cabos-eletrodos transvenosos. Objetivo: apresentar uma reflexão sobre como praticar o uso racional do implante de cabos-eletrodos e propor estratégias e alternativas para postergá-lo ou evitá-lo, com base nos conhecimentos atuais nos diversos campos da estimulação cardíaca artificial. Métodos: Revisão da literatura que utilizou artigos de 1995 a 2019, de diversas plataformas e revistas. Conclusão:Há a expectativa de que nos próximos anos ocorram avanços tecnológicos e de conhecimento no campo da estimulação leadless, permitindo que esses dispositivos sejam incorporados na prática clínica de maneira rotineira. Atualmente, se o implante de eletrodos ventriculares nos casos de doença do nó sinusal com condução atrioventricular preservada for racionalizado, o implante de eletrodos atriais nos cardiodesfibriladores implantáveis (CDI) sem necessidade de estimulação antibradicardia ou dos eletrodos ventriculares nos casos sem a necessidade de estimulação antitaquicardia (ATP) considerando o implante de CDIs subcutâneos, este artigo terá cumprido o seu papel.

Rational Use of Leads in Artificial Cardiac Pacing

Introduction: Cardiovascular implantable electronic device (CIEDs) are a proven therapy for the treatment of bradyarrhythmias, prevention of sudden death or heart failure. Since the first transvenous pacemaker implantation more than 60 years ago, technological advances in devices and improvements in surgical techniques have occurred. However, this type of therapy is still associated with significant complications, most of them related to the implantation of transvenous leads. Objective: To present a reflection on how to practice the rational use of lead implantation and propose strategies and alternatives to delay or avoid it, based on the current knowledge in the various fields of artificial cardiac stimulation. Methods: Review of literature that used articles from 1995 to 2019, from several platforms and periodicals. Conclusion: There is an expectation that in the coming years there will be technological and knowledge advances in the field of leadless stimulation, allowing these devices to be incorporated into clinical practice in a routine manner. Currently, if the implantation of ventricular electrodes in cases of sinus node disease with preserved atrioventricular conduction is rationalized, the implantation of atrial electrodes in implantable cardioverter-defibrillators (ICD) without the necessity of antibradicardia stimulation or ventricular electrodes in cases without the necessity of antitachycardia stimulation (ATP) considering the subcutaneous ICD implantation, this article will have fulfilled its role.